More specifically, loss of Sema3A favors the angiogenic effect of Vascular Endothelial Growth Factor165 and may be involved in the angiogenic transition from monoclonal gammopathy of undetermined significance to MM5. The gene discussed is SEMA3A; the disease is monoclonal gammopathy.